MET gene copy number heterogeneity in non-small cell lung cancer patients resistant to EGFR-TKIs

被引：0
|
作者：
Bai, Q. [1 ]
Chen, Y. [1 ]
Xiao, X. [2 ]
Chang, H. [1 ]
Xin, B. [2 ]
Jia, L. [1 ]
Li, J. [2 ]
Wang, Z. [1 ]
Yu, C. [1 ]
Xiong, H. [3 ]
Zhou, X. [1 ]
机构：
[1] Fudan Univ, Pathol, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Shanghai Yuanqi Biomed Technol Co Ltd, Shanghai, Peoples R China
[3] Shanghai Rightongene Biotechnol Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
203P
引用
收藏
页码：S150 / S151
页数：2
相关论文
共 50 条
  • [41] Correlation Between MET Gene Copy Number and Molecular Profiling in Non-Small Cell Lung Cancer
    Fang, Lianghua
    Chen, Hui
    Medeiros, L. Jeffrey
    Hu, Shimin
    Pei, Lin
    Luthra, Raja
    Singh, Rajesh R.
    Routbort, Mark J.
    Hong, David
    Lu, Xinyan
    LABORATORY INVESTIGATION, 2017, 97 : 478A - 478A
  • [42] Appetite Loss as an Adverse Effect During Treatment with EGFR-TKIs in Elderly Patients with Non-small Cell Lung Cancer
    Inomata, Minehiko
    Shimokawa, Kazuki
    Tokui, Kotaro
    Taka, Chihiro
    Okazawa, Seisuke
    Kambara, Kenta
    Yamada, Toru
    Miwa, Toshiro
    Hayashi, Ryuji
    Kashii, Tatsuhiko
    Matsui, Shoko
    Tobe, Kazuyuki
    ANTICANCER RESEARCH, 2016, 36 (09) : 4951 - 4954
  • [43] Long QT syndrome after using EGFR-TKIs in older patients with advanced non-small cell lung cancer
    Byun, Joo-Young
    Han, Sola
    Qdaisat, Aiham
    Park, Chanhyun
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (08) : 1007 - 1015
  • [44] Non-small cell lung cancer: Classical tumor markers versus EGFR gene copy number
    Valina Amado, L.
    Enver Sumaya, M.
    Azkarate Martinez, A.
    Martinez Font, E.
    Parera Rossello, M. M.
    Obrador De Hevia, A.
    CLINICA CHIMICA ACTA, 2019, 493 : S159 - S160
  • [45] Identification of Genomic Alterations Acquired During Treatment With EGFR-TKIs in Non-small Cell Lung Cancer
    Kubo, Naoki
    Harada, Taishi
    Shiraishi, Yoshimasa
    Nosaki, Kaname
    Nakagaki, Noriaki
    Takeshita, Masafumi
    Ouchi, Hiroshi
    Iwama, Eiji
    Tanaka, Kentaro
    Okamoto, Isamu
    Sasaki, Hiroyuki
    Nakanishi, Yoichi
    ANTICANCER RESEARCH, 2019, 39 (02) : 671 - 677
  • [46] Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs
    Tanaka, Hidenori
    Kimura, Tatsuo
    Kudoh, Shinzoh
    Mitsuoka, Shigeki
    Watanabe, Tetsuya
    Suzumura, Tomohiro
    Tachibana, Keisei
    Noguchi, Masayuki
    Yano, Seiji
    Hirata, Kazuto
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (06) : 1410 - 1416
  • [47] Pilot Study of EGFR-TKIs in Combination with Radiation for Patients with Locally Advanced and Metastatic Non-small Cell Lung Cancer
    Wang, J.
    Xia, T.
    Wang, Y.
    Li, H.
    Zhang, Y.
    Li, P.
    Wang, J.
    Chang, D.
    Sun, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S445 - S445
  • [48] Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With EGFR Mutations
    Jia, Yijun
    Li, Xuefei
    Zhao, Chao
    Ren, Shengxiang
    Su, Chunxia
    Gao, Guanghui
    Li, Wei
    Zhou, Fei
    Li, Jiayu
    Zhou, Caicun
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [49] Epithelial phenotype as a predictive marker for response to EGFR-TKIs in non-small cell lung cancer patients with wild-type EGFR
    Ren, Shengxiang
    Su, Chunxia
    Wang, Zhaoye
    Li, Jiayu
    Fan, Lihong
    Li, Bing
    Li, Xuefei
    Zhao, Cao
    Wu, Chunyan
    Hou, Likun
    He, Yayi
    Gao, Guanghui
    Chen, Xiaoxia
    Ren, Jiawei
    Li, Aiwu
    Xu, Guotong
    Zhou, Xiao
    Zhou, Caicun
    Schmid-Bindert, Gerald
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (12) : 2962 - 2971
  • [50] Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance
    Li, Fang
    Zhu, Tengjiao
    Cao, Baoshan
    Wang, Jiadong
    Liang, Li
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 184 - 192
12345